Tunneling Nanotubes: A New Target for Nanomedicine?
Open Access
- 17 February 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (4) , 2237
Abstract
Tunneling nanotubes (TNTs), discovered in 2004, are thin, long protrusions between cells utilized for intercellular transfer and communication. These newly discovered structures have been demonstrated to play a crucial role in homeostasis, but also in the spreading of diseases, infections, and metastases. Gaining much interest in the medical research field, TNTs have been shown to transport nanomedicines (NMeds) between cells. NMeds have been studied thanks to their advantageous features in terms of reduced toxicity of drugs, enhanced solubility, protection of the payload, prolonged release, and more interestingly, cell-targeted delivery. Nevertheless, their transfer between cells via TNTs makes their true fate unknown. If better understood, TNTs could help control NMed delivery. In fact, TNTs can represent the possibility both to improve the biodistribution of NMeds throughout a diseased tissue by increasing their formation, or to minimize their formation to block the transfer of dangerous material. To date, few studies have investigated the interaction between NMeds and TNTs. In this work, we will explain what TNTs are and how they form and then review what has been published regarding their potential use in nanomedicine research. We will highlight possible future approaches to better exploit TNT intercellular communication in the field of nanomedicine.Keywords
Funding Information
- IMI EU Grant “Investigating Mechanisms and Models predictive of accessibility of therapeutics (IM2PACT) Into the Brain” IMI2 - Call 12, (im2pact.org) (GA n.807015)
- a Ministero degli Esteri e della Cooperazione Internazionale MAECI grant, Progetti di ricerca scientifica e tecnologica di grande rilevanza by Ministero degli Esteri, Progetti Italy-USA, “Nanomedicine for Blood Brain Barrier (BBB)-crossing in CNS oncologi (MAE00691612020-06-26)
- FAR Unimore Fondazione di Modena “Nano-immuno targeting per il trattamento del glioblastoma multiforme” NIT Project; GLIOSILK Project (EURONANOMED2019-075)
- Creutzfeldt–Jakob disease Foundation (CJDF) (01)
- Telethon project: “Pigment Epithelium-derived Factor (PEDF) peptide as therapeutic agents for inherited retinal degeneration” (GGP19113)
This publication has 156 references indexed in Scilit:
- Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistanceJournal of Translational Medicine, 2013
- Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma TreatmentMolecular Therapy Nucleic Acids, 2013
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298The American Journal of Pathology, 2012
- Multi-Level Communication of Human Retinal Pigment Epithelial Cells via Tunneling NanotubesPLOS ONE, 2012
- Tunneling Nanotubes Provide a Unique Conduit for Intercellular Transfer of Cellular Contents in Human Malignant Pleural MesotheliomaPLOS ONE, 2012
- Different Modalities of Intercellular Membrane Exchanges Mediate Cell-to-cell P-glycoprotein Transfers in MCF-7 Breast Cancer CellsJournal of Biological Chemistry, 2012
- Arachidonic Acid Randomizes Endothelial Cell Motion and Regulates Adhesion and MigrationPLOS ONE, 2011
- Intercellular Communication by Exchange of Cytoplasmic Material via Tunneling Nano-Tube Like Structures in Primary Human Renal Epithelial CellsPLOS ONE, 2011
- Intercellular Bridges in Vertebrate GastrulationPLOS ONE, 2011
- Neural crest cell communication involves an exchange of cytoplasmic material through cellular bridges revealed by photoconversion of KikGRDevelopmental Dynamics, 2011